IP Library Granted Patent US 12,515,045
Granted Patent B2
US 12,515,045 · App. 18/750,582 · Granted Jan 6, 2026

Treatment planning for tumor treating fields

Inventors: Zeev Bomzon (Haifa, IL); Hadas Sara Hershkovich (Haifa, IL); Noa Urman (Haifa, IL); Oren Ben Zion Bakalo (Haifa, IL); Gil Zigelman (Haifa, IL); Reuven Ruby Shamir (Haifa, IL)
Assignee: Novocure GmbH
A61N1/36002A61N1/025A61N1/0476A61N1/36031A61N1/36034G16H15/00G16H30/20G16H50/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,515,045
App. No.
18/750,582
Granted
Jan 6, 2026
Kind
B2
Abstract

A method for generating a transducer layout for delivering tumor treating fields includes storing medical images of a subject, identifying one of the medical images as an anchor medical image, and registering computed tomography medical images with magnetic resonance imaging medical images. The method further includes segmenting abnormal tissue in the medical images from other tissue types and defining a region of interest (ROI) in the medical images. The method further includes creating a 3D model of the subject. The method further includes generating a plurality of transducer layouts for application of tumor treating fields to the subject, selecting at least two of the transducer layouts as recommended transducer layouts, presenting the recommended transducer layouts, receiving a user selection of at least one recommended transducer layout, and providing a report for the selected recommended transducer layout(s).

Claims (83)

1 . A computer-implemented method for generating at least one transducer layout for delivering tumor treating fields to a subject, the method comprising:

storing in memory a plurality of medical images of a subject, the medical images comprising magnetic resonance imaging (MRI) medical images and computed tomography (CT) medical images, the medical images comprising voxels;

identifying one of the medical images as an anchor medical image, the anchor medical image being used to fix the medical images for creating a three-dimensional model of the subject;

registering the CT medical images with the MRI medical images;

segmenting abnormal tissue in the medical images from other tissue types in the medical images;

defining a region of interest (ROI) in the medical images for application of tumor treating fields to the subject;

creating the three-dimensional model of the subject based on the anchor medical image, the medical images, and tissue types in the medical images, wherein the ROI in the medical images is part of the three-dimensional model;

receiving an adjustment to the ROI to address a calculation warning provided via a user interface;

generating a plurality of transducer layouts for application of tumor treating fields to the subject based on the three-dimensional model of the subject;

selecting at least two of the transducer layouts as recommended transducer layouts;

presenting the recommended transducer layouts;

receiving a user selection of at least one recommended transducer layout; and

providing a report for the at least one selected recommended transducer layout,

wherein the calculation warning indicates at least one of:

the ROI in the medical images does not contain a minimum number of gray and/or white matter voxels;

the ROI in the medical images does not contain a minimum number of enhancing tumor voxels; or

only regions of interest having gray and/or white matter voxels or enhancing tumor voxels will be presented.

2 . The method of claim 1 , wherein after the CT medical images are registered with the MRI medical images, the CT medical images are aligned and linked with the MRI medical images.

3 . The method of claim 1 , wherein segmenting the abnormal tissue is based on user input identifying abnormal tissue in the medical images.

4 . The method of claim 1 , further comprising storing in memory a radiation therapy segmentation of the medical images,

wherein segmenting the abnormal tissue is based on the radiation therapy segmentation.

5 . The method of claim 1 , wherein the abnormal tissue includes at least one of tumor, necrotic tissue, or prior surgical area.

6 . The method of claim 1 , wherein defining the ROI in the medical images comprises defining a gross tumor volume (GTV) and a clinical target volume (CTV) in the medical images.

7 . The method of claim 1 , wherein defining the ROI in the medical images comprises defining a proximal boundary zone (PBZ) in the medical images.

8 . The method of claim 1 , wherein defining the ROI in the medical images comprises defining a gross tumor volume (GTV) and a proximal boundary zone (PBZ) in the medical images and defining a clinical target volume (CTV) in the medical images by combining the GTV and PBZ.

9 . The method of claim 1 , wherein creating the three-dimensional model of the subject comprises assigning tissue types and associated conductivities to voxels of the three-dimensional model of the subject.

10 . The method of claim 1 , wherein the plurality of the transducer layouts includes four locations on the subject to place four respective transducer arrays.

11 . The method of claim 10 , wherein each of the transducer arrays comprises a plurality of electrode elements, wherein at least one electrode element comprises a ceramic dielectric layer.

12 . The method of claim 10 , wherein each of the transducer arrays comprises a plurality of electrode elements, wherein at least one electrode element comprises a polymer film.

13 . The method of claim 1 , wherein at least one of the recommended transducer layouts has a highest dose of tumor treating fields delivered to the ROI.

14 . The method of claim 1 , wherein at least one of the recommended transducer layouts is a transducer layout that is in a shifted or rotated position compared to a transducer layout having a highest dose of tumor treating fields delivered to the ROI.

15 . The method of claim 1 , wherein presenting the recommended transducer layouts comprises presenting information on the recommended transducer layouts via a user interface, wherein the information is presented as at least one of:

doses of tumor treating fields delivered to the ROI for each of the recommended transducer layouts;

a medical image slice overlaid with a dose of tumor treating fields for at least one recommended transducer layout;

a two-dimensional graph comparing percentage volume of ROI and percentage dose of tumor treating fields for at least one recommended transducer layout;

an image of the subject depicting locations of electrode elements for at least one recommended transducer layout;

a two-dimensional graph depicting a cumulative dose of tumor treating fields across the ROI for at least one recommended transducer layout;

a two-dimensional graph depicting a dose of tumor treating fields across the ROI for at least one recommended transducer layout;

a percentage of overlap between electrode elements of two recommended transducer layouts; or

a percentage of overlap between adhesive portions of two recommended transducer layouts.

16 . The method of claim 1 , wherein receiving a user selection of at least one recommended transducer layout comprises receiving a selection of a primary transducer layout and an alternative transducer layout.

17 . The method of claim 1 , wherein the report for at least one selected recommended transducer layout displays locations of transducer arrays of the selected recommended transducer layout on the subject in a plurality of views.

18 . The method of claim 1 , wherein during generating the plurality of the transducer layouts, the method further comprises:

determining whether the ROI in the medical images contains the minimum number of gray and/or white matter voxels;

determining whether the ROI in the medical images contains the minimum number of enhancing tumor voxels; and

determining whether only regions of interest having gray and/or white matter voxels or enhancing tumor voxels will be presented.

19 . The method of claim 18 , wherein if the calculation warning indicates that the ROI in the medical images does not contain a minimum number of gray and/or white matter voxels, receiving a revision of the ROI in the medical images to include additional gray and/or white matter voxels,

wherein if the calculation warning indicates that the ROI in the medical images does not contain a minimum number of enhancing tumor voxels, receiving a revision of the ROI in the medical images to include additional enhancing tumor voxels, and

wherein if the calculation warning indicates that only regions of interest having gray and/or white matter voxels or enhancing tumor voxels will be presented, receiving a revision of a size of the ROI in the medical images so voxels not in the ROI will be presented.

20 . An apparatus for generating at least one transducer layout for delivering tumor treating fields to a subject, the apparatus comprising: one or more processors; and

memory accessible by the one or more processors, the memory storing instructions that when executed by the one or more processors, cause the apparatus to:

store in memory a plurality of medical images of a subject, the medical images comprising magnetic resonance imaging (MRI) medical images and computed tomography (CT) medical images, the medical images comprising voxels;

identify one of the medical images as an anchor medical image, the anchor medical image being used to fix the medical images for creating a three-dimensional model of the subject;

register the CT medical images with the MRI medical images;

segment abnormal tissue in the medical images from other tissue types in the medical images;

define a region of interest (ROI) in the medical images for application of tumor treating fields to the subject;

create the three-dimensional model of the subject based on the anchor medical image, the medical images, and tissue types in the medical images, wherein the region of interest in the medical images is part of the three-dimensional model;

receive an adjustment to the ROI to address a calculation warning provided via a user interface;

generate a plurality of transducer layouts for application of tumor treating fields to the subject based on the three-dimensional model of the subject;

select at least two of the transducer layouts as recommended transducer layouts;

present the recommended transducer layouts;

receive a user selection of at least one recommended transducer layout; and

provide a report for the at least one selected recommended transducer layout,

wherein the calculation warning indicates at least one of:

the ROI in the medical images does not contain a minimum number of gray and/or white matter voxels;

the ROI in the medical images does not contain a minimum number of enhancing tumor voxels; or

only regions of interest having gray and/or white matter voxels or enhancing tumor voxels will be presented.

21 . A non-transitory processor readable medium containing a set of instructions thereon for generating at least one transducer layout for delivering tumor treating fields to a subject, wherein when executed by a processor, the instructions cause the processor to: store in memory a plurality of medical images of a subject, the medical images comprising magnetic resonance imaging (MRI) medical images and computed tomography (CT) medical images, the medical images comprising voxels;

identify one of the medical images as an anchor medical image, the anchor medical image being used to fix the medical images for creating a three-dimensional model of the subject;

register the CT medical images with the MRI medical images;

segment abnormal tissue in the medical images from other tissue types in the medical images;

define a region of interest (ROI) in the medical images for application of tumor treating fields to the subject;

create the three-dimensional model of the subject based on the anchor medical image, the medical images, and tissue types in the medical images, wherein the region of interest in the medical images is part of the three-dimensional model;

receive an adjustment to the ROI to address a calculation warning provided via a user interface;

generate a plurality of transducer layouts for application of tumor treating fields to the subject based on the three-dimensional model of the subject;

select at least two of the transducer layouts as recommended transducer layouts;

present the recommended transducer layouts;

receive a user selection of at least one recommended transducer layout; and

provide a report for the at least one selected recommended transducer layout,

wherein the calculation warning indicates at least one of:

the ROI in the medical images does not contain a minimum number of gray and/or white matter voxels;

the ROI in the medical images does not contain a minimum number of enhancing tumor voxels; or

only regions of interest having gray and/or white matter voxels or enhancing tumor voxels will be presented.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2024
From: BOMZON, ZEEV; HERSHKOVICH, HADAS SARA; URMAN, NOA; BAKALO, OREN BEN ZION; ZIGELMAN, GIL; SHAMIR, REUVEN RUBY
To: NOVOCURE GMBH
Reel/Frame 067802/0952 →
Continuity (2)
Provisional Application 63524470 · Jun 30, 2023
Related Publication 20250001168A1 · Jan 2, 2025
References Cited (67)
US 6553152B1 · Miller et al. · 2003 [cited by applicant]
US 7376252B2 · Gritzky et al. · 2008 [cited by applicant]
US 7565205B2 · Palti · 2009 [cited by applicant]
US 8019133B2 · Knoplioch et al. · 2011 [cited by applicant]
US 8547402B2 · Kreeger et al. · 2013 [cited by applicant]
US 8689127B1 · Ding et al. · 2014 [cited by applicant]
US 8819591B2 · Wang et al. · 2014 [cited by applicant]
US 9135400B2 · McIntyre et al. · 2015 [cited by applicant]
US 9678620B2 · Wiemker et al. · 2017 [cited by applicant]
US 9710730B2 · Konukoglu et al. · 2017 [cited by applicant]
US 9848799B2 · Govari et al. · 2017 [cited by applicant]
US 10096382B2 · Zhu et al. · 2018 [cited by applicant]
US 10147185B2 · Riklin Raviv et al. · 2018 [cited by applicant]
US 10188851B2 · Wenger et al. · 2019 [cited by applicant]
US 10203395B2 · Foxall et al. · 2019 [cited by applicant]
US 10286216B2 · Stone et al. · 2019 [cited by applicant]
US 10740933B2 · Tripathi et al. · 2020 [cited by applicant]
US 10966688B2 · Fialkov · 2021 [cited by applicant]
US 11020077B2 · Wang et al. · 2021 [cited by applicant]
US 11109773B2 · Urman et al. · 2021 [cited by applicant]
US 11282193B2 · Harrison et al. · 2022 [cited by applicant]
US 11417071B1 · Douglas et al. · 2022 [cited by applicant]
US 11423603B2 · Sutton et al. · 2022 [cited by applicant]
US 11620789B2 · Hershkovich et al. · 2023 [cited by applicant]
US 11625151B2 · Gulaka et al. · 2023 [cited by applicant]
US 20050036668A1 · McLennan et al. · 2005 [cited by applicant]
US 20050228250A1 · Bitter et al. · 2005 [cited by applicant]
US 20060177133A1 · Kee · 2006 [cited by applicant]
US 20090251465A1 · Hassenpflug · 2009 [cited by applicant]
US 20130074005A1 · Whitman et al. · 2013 [cited by applicant]
US 20160042537A1 · Ng et al. · 2016 [cited by applicant]
US 20180160933A1 · Urman et al. · 2018 [cited by applicant]
US 20200146586A1 · Naveh · 2020 [cited by examiner]
US 20200219261A1 · Shamir et al. · 2020 [cited by applicant]
US 20200372705A1 · Hershkovich · 2020 [cited by examiner]
US 20210038314A1 · Wibowo · 2021 [cited by applicant]
US 20210162228A1 · Urman et al. · 2021 [cited by applicant]
US 20210187289A1 · Munster · 2021 [cited by examiner]
US 20210201572A1 · Bomzon · 2021 [cited by applicant]
US 20210299439A1 · Shamir et al. · 2021 [cited by applicant]
US 20210327105A1 · Morard et al. · 2021 [cited by applicant]
US 20220096853A1 · Bakalo · 2022 [cited by examiner]
US 20220139531A1 · Wang et al. · 2022 [cited by applicant]
US 20220151037A1 · Taniguchi · 2022 [cited by examiner]
US 20220245821A1 · Ouzounis · 2022 [cited by applicant]
US 20220284585A1 · Holtzman Gazit et al. · 2022 [cited by applicant]
US 20220292687A1 · Yuzawa · 2022 [cited by applicant]
US 20220414883A1 · Shinagawa et al. · 2022 [cited by applicant]
US 20230082049A1 · Moreau · 2023 [cited by applicant]
US 20230143748A1 · Butler et al. · 2023 [cited by applicant]
US 20230206548A1 · Hershkovich et al. · 2023 [cited by applicant]
EP 3731179A1 · 2020 [cited by applicant]
WO WO2013155358A1 · 2013 [cited by applicant]
WO WO2021111186A1 · 2021 [cited by applicant]
WO WO2022185222A1 · 2022 [cited by applicant]
Bevacqua et al., “A Method for Effective Permittivity and Conductivity Mapping of Biological Scenarios via Segmented Contrast Source Inversion,” 2019. [cited by applicant]
Chowdhury et al., “Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning,” Apr. 3, 2012. [cited by applicant]
Davis et al., “LeGUI: A Fast and Accurate Graphical User Interface for Automated Detection and Anatomical Localization of Intracranial Electrodes,” Dec. 9, 2021. [cited by applicant]
Paiement et al., “Integrated Segmentation and Interpolation of Sparse Data,” 2013. [cited by applicant]
Iredale, et al., “Planning system for the optimization of electric field delivery using implanted electrodes for brain tumor control,” Sep. 1, 2022. [cited by applicant]
Cates, et al., “GIST: An Interactive, GPU-Based Level Set Segmentation Tool for 3D Medical Images,” Feb. 27, 2004. [cited by applicant]
Rivest-Henault et al., “Robust inverse-consistent affine CT-MR registration in MRI-assisted and MRI-alone prostate radiation therapy,” Apr. 24, 2015. [cited by applicant]
Timmons et al., “End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas,” Oct. 11, 2017. [cited by applicant]
Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial by Ballo MT et al., … [cited by applicant]
Wenger et al., “A Review on Tumor-Treating Fields (TTFIELDS): Clinical Implications Inferred from Computational Modeling,” IEEE Reviews in Biomedical Engineering, vol. 11, Feb. 13, 2018, pp. 195-207. [cited by applicant]
Urman et al., “Investigating the Connection Between Tumor-Treating Fields Distribution in the Brain and Glioblastoma Patient Outcomes. A Simulation-Based Study Utilizing a Novel Model Creating Technique: Computational H… [cited by applicant]
M. Joliot and B.M. Mazoyer, “Three-dimensional segmentation and interpolation of magnetic resonance brain images,” in IEEE Transactions on Medical Imaging, vol. 12, No. 2, pp. 269-277, Jun. 1993, doi: 10.1109/42.232255.… [cited by applicant]